«For many years, pharmaceutical companies have rejected the principle that medical-scientific information should be addressed to all family doctors, regardless of the treatment plan. I hope that they will now collaborate with us rather than become champions of medical-scientific information on their own".
SUNDAY 16 NOVEMBER 2014 – healthesk
From next December, family doctors will go to school to learn how to manage the most innovative drugs that are already or are coming to the market. Not all, however: for now there will be 2,000 selected from those who have joined the AIFA project, the Italian Medicines Agency, which will allow them to prescribe medicines subject to a therapeutic plan, so far only prescribed by specialist doctors.
«For many years – he underlines Claudio Cricelli, president of Simg, the Italian Society of General Medicine - the innovative drugs subjected to the therapeutic plan are not the subject of scientific information addressed to general practitioners. But this situation is destined to change radically.
Cricelli recalls that the Scientific Society has "strongly supported" the AIFA project and now "we want to offer training opportunities to family doctors". That's why he decided to create, inside of the high school of Simg, the first high school of medicine. «Pharmaceutical companies – says Cricelli – for many years have rejected the principle that medical-scientific information should be addressed to all family doctors, regardless of the treatment plan. I hope that they will now collaborate with us rather than become champions of medical-scientific information on their own". The president of Simg explains that the School will provide training "directly" to its professionals and will not limit itself to the content of the leaflet, but will teach the management of the drug within the complexity of the treatment process. The Aifa project «is the recognition of the great ability of general medicine to appropriately manage each drug. The school represents an indispensable tool for the management training of white coats. For too many years, even without knowledge of new drugs and their side effects, we have taken care of patients who were prescribed these drugs by specialists. And we have not shirked our responsibilities. Simg - concludes Cricelli - has tried to make up for these problems, guaranteeing in any case training for family doctors".
